Griseofulvin-warfarin antagonism
- 20 February 1967
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 199 (8), 582-583
- https://doi.org/10.1001/jama.199.8.582
Abstract
THE DEMONSTRATION that the metabolism of one drug can alter the metabolism of another has occasioned considerable interest.1Recent experimental work has shown that an increase within cells of the liver of smooth-surfaced endoplasmic reticulum parallels an increase of this altered metabolism.2Of further interest is the fact that the same or similar loci seem to be implicated in cholesterol synthesis.3Because it has been reported that the metabolism of both griseofulvin and coumarin congeners are increased by treatment with phenobarbital, presumably via enzyme induction,4,5it seemed within reason that one of these might act as an inducer to accelerate metabolism of the other. It should be noted, however, that the fact that a drug either acts as an inducer or is subject to altered metabolism via enzyme induction does not necessarily indicate that it will function in both capacities. Report of Cases Case 1.— AThis publication has 5 references indexed in Scilit:
- Increased Cholesterol Biosynthesis Following Phenobarbital Induced Hypertrophy of Agranular Endoplasmic Reticulum in Liver.Experimental Biology and Medicine, 1965
- Drug interactions in manClinical Pharmacology & Therapeutics, 1965
- PHENOBARBITAL-INDUCED SYNTHESIS OF THE MICROSOMAL DRUG-METABOLIZING ENZYME SYSTEM AND ITS RELATIONSHIP TO THE PROLIFERATION OF ENDOPLASMIC MEMBRANESThe Journal of cell biology, 1965
- Effective Use of GriseofulvinArchives of Dermatology, 1963
- The metabolism of griseofulvin in mammalsBiochemical Journal, 1961